ACGT

ACGT aims to present the 'next-step' in cancer research and fill-in the technological gaps of clinical trials targeting two forms of cancer: breast cancer and paediatric nephroblastoma. ACGT will develop a Biomedical GRID infrastructure supporting seamless mediation services for sharing clinical and genomic expertise. It will help to identify quicker and more efficiently the characteristics that determine what form of treatment best suits which patient.

ACGT aims to provide researchers and patients with the best means and resources to fight cancer. ACGT is working towards the rapid identification of cancer profiles and best treatments. The ACGT project will:

  • Define common standards of data storage at each level of investigation.
  • Develop new ontologies for cross-referencing terms and their biological contexts.
  • Implement a bio-medical GRID infrastructure offering seamless mediation services for sharing data and dataprocessing.

ACGT will therefore deliver a unifying infrastructure allowing cancer researchers to share their data and to benefit from the innovative informatics tools that are being developed by other researchers.

For further information, please visit:
http://www.eu-acgt.org

Project co-ordinator:
ERCIM EEIG

Partners:

  • ERCIM EEIG - Institut National de Recherche en Informatique et en Automatique - Healthgrid (FR)
  • Foundation for Research and Technology Hellas - A. Persidis & SIA O.E. - University of Crete - Institute of Communications and Computer Systems (GR)
  • University van Amsterdam - Philips Electronics Nederland B.V. (NL)
  • Association Hospitaliere de Bruxelles – Centre Hospitalier Universitaire Bordet – Custodix - Facultes Universitaires Notre-Dame de la Paix (BE)
  • Institut Suisse de Bioinformatique (CH)
  • Lunds Universitet (SE)
  • Universidad de Malaga - Universidad Politechnica de Madrid (ES)
  • Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung - Unisersitaet Hannover - Universitaet des Saarland - Universitaet Hamburg (DE)
  • Instytut Chemii Biooganicznej pan w Poznaniu (PL)
  • S.C. SIVECO ROMANIA SA (RO)
  • The Chancellor, Masters and Scholars of the University of Oxford (UK)
  • Hokkaido University (JP)
  • Istituto Europeo di Oncologia s.r.l. (IT)

Timetable: from 02/06 - to 01/10

Total cost: € 16. 747.206

EC funding: € 11. 887.000

Instrument: Integrated Project

Project Identifier: IST-2004-026996

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...